Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-08

Clinical Trial Update: Effect of Splitting Mealtime Insulin Doses After Mixed Meals High in Fat and Protein [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether splitting mealtime insulin doses after high-fat/protein mixed meals improves outcomes in type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sohag University | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: COMPLETED